Skip to main content
logo
Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.920
-0.030 (-0.76%)
At close: Sep 15, 2025, 4:00 PM EDT
3.920
0.00 (0.01%)
After-hours: Sep 15, 2025, 5:15 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Oncolytic Immunotherapies
8.00K
Log In
Log In
Oncolytic Immunotherapies Growth
-95.29%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
8.00K
Log In
Log In
United States Growth
-95.29%
Log In
Log In